Work

Alliance A091102: Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.10527

Authors: Mark Andrew Dickson, Michelle R. Mahoney, William D. Tap, Sandra P. D'Angelo, Mary Louise Keohan, Brian Andrew Van Tine, Mark Agulnik, Laura E. Horvath, Gary K. Schwartz

Institutions: Memorial Sloan Kettering Cancer Center, Mayo Clinic, Washington University in St. Louis, Northwestern University, Alliance for Clinical Trials in Oncology, Columbia University Irving Medical Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4233032485

Cites:

Cited by: 3

Related to: 10